US EditionAscentage Pharma Appoints Dr. Veet Misra as CFO and Eric Huang as SVP of Global Corporate Development and Finance
3 Articles
3 Articles
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance - Ascentage Pharma Group (NASDAQ:AAPG)
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ:AAPG, HKEX: 6855)) ("Ascentage Pharma" or the "Company"), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company's Chief Financial Officer, and Mr. Eric Huang, as Senior Vice President of Global Corporate Development and Finance. Both D…
ROCKVILLE, Md. and SUZHOU, China, July 8, 2025 /PRNewswire/ -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a leading biopharmaceutical company developing innovative drugs in oncology and other fields, announced the appointment of Dr. Veet Misra as Chief Financial Officer and Mr. Zhi Huang as Senior Vice President of Global Corporate Development & Finance. Both Dr. Misra and Mr. Zhi Huang report directly to Dr. Dajun Yang, Chairman and CEO of th…
Ascentage Pharma Appoints Dr. Veet Misra as CFO and Eric Huang as SVP of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief Financial Officer, and Mr. Eric Huang, as Senior Vice President of Global Corporate Development and Finance. Both Dr. Misra and Mr. Huang will report dire…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
